A discrete event model of clinical trial enrollment at Eli Lilly and company

Proceedings - Winter Simulation Conference

Volumn , Issue , 2007, Pages 1467-1474

  McGarvey, Bernard M ^a   Dynes, Nancy J ^a   Lin, Burch C ^a   Anderson, Wesley H ^a   Kremidas, James P ^a   Felli, James C ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORINE COMPOUNDS;

ACCURATE PREDICTION; CLINICAL TRIALS; CPU TIMES; DISCRETE-EVENT MODELING; ELI LILLY; PHARMACEUTICAL COMPANIES; RESOURCE INTENSIVE; SIGNIFICANT REDUCTION;

FORECASTING;

EID: 49749098888     PISSN: 08917736     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/WSC.2007.4419758     Document Type: Conference Paper

References (5)

1. Banks, J., J. S. Carson, B. L. Nelson, and D. M. Nicol. 2000. Discrete-event system simulation. 3rd ed. Upper Saddle River, New Jersey: Prentice-Hall, Inc.
2. Felli, J. C., W. H. Anderson, J. P. Kremidas, and S. J. Ruberg. 2007. A semi-Markov model for patient progression through clinical trials. European Journal of Operational Research 176:542-9.
3. Fishman, G. 2001. Discrete-event simulation. USA: Springer.
4. Leemis, L., and S. Park. 2005. Discrete-event simulation: A first course, USA: Prentice Hall.
5. Laguna, M., and M. Marklund. 2004. Business process modeling, simulation, and design, USA: Prentice Hall.